Syngene International Reports Robust Q4 Results, Declares Dividend Reward

Syngene International Ltd. has announced its financial results for the quarter ended March, with robust growth and rewarding its shareholders with a dividend. The company once again proves its leadership in the life sciences and contract research space. The highlights are as follows:

 

Consolidated Revenue from Operations: Syngene registered a consolidated revenue of ₹10.18 billion in the March quarter, showcasing its impressive operational performance and steady market demand.

 

Net Profit After Tax (PAT): The company secured a consolidated net PAT of ₹1.83 billion, highlighting its profitability and sound financial position.

 

Dividend Declaration: The Board of Directors declared a dividend of ₹1.25 per equity share, as a gesture of appreciation for shareholders' persistent confidence and support.

 

These findings reflect Syngene International's robust financial position and its focus on creating value for stakeholders.

 

Sources: Syngene Financial Overview, Quarterly Performance Insights